Literature DB >> 27437783

Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls.

Lingli Deng1,2, Haiwei Gu2,3, Jiangjiang Zhu2, G A Nagana Gowda2, Danijel Djukovic2, E Gabriela Chiorean4,5, Daniel Raftery2,6,7.   

Abstract

Both nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) play important roles in metabolomics. The complementary features of NMR and MS make their combination very attractive; however, currently the vast majority of metabolomics studies use either NMR or MS separately, and variable selection that combines NMR and MS for biomarker identification and statistical modeling is still not well developed. In this study focused on methodology, we developed a backward variable elimination partial least-squares discriminant analysis algorithm embedded with Monte Carlo cross validation (MCCV-BVE-PLSDA), to combine NMR and targeted liquid chromatography (LC)/MS data. Using the metabolomics analysis of serum for the detection of colorectal cancer (CRC) and polyps as an example, we demonstrate that variable selection is vitally important in combining NMR and MS data. The combined approach was better than using NMR or LC/MS data alone in providing significantly improved predictive accuracy in all the pairwise comparisons among CRC, polyps, and healthy controls. Using this approach, we selected a subset of metabolites responsible for the improved separation for each pairwise comparison, and we achieved a comprehensive profile of altered metabolite levels, including those in glycolysis, the TCA cycle, amino acid metabolism, and other pathways that were related to CRC and polyps. MCCV-BVE-PLSDA is straightforward, easy to implement, and highly useful for studying the contribution of each individual variable to multivariate statistical models. On the basis of these results, we recommend using an appropriate variable selection step, such as MCCV-BVE-PLSDA, when analyzing data from multiple analytical platforms to obtain improved statistical performance and a more accurate biological interpretation, especially for biomarker discovery. Importantly, the approach described here is relatively universal and can be easily expanded for combination with other analytical technologies.

Entities:  

Mesh:

Year:  2016        PMID: 27437783      PMCID: PMC5450811          DOI: 10.1021/acs.analchem.6b00885

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  64 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Metabolomics as a tool for cardiac research.

Authors:  Julian L Griffin; Helen Atherton; John Shockcor; Luigi Atzori
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

Review 3.  Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.

Authors:  Warwick B Dunn; David I Broadhurst; Helen J Atherton; Royston Goodacre; Julian L Griffin
Journal:  Chem Soc Rev       Date:  2010-08-17       Impact factor: 54.564

4.  Principal component analysis of urine metabolites detected by NMR and DESI-MS in patients with inborn errors of metabolism.

Authors:  Zhengzheng Pan; Haiwei Gu; Nari Talaty; Huanwen Chen; Narasimhamurthy Shanaiah; Bryan E Hainline; R Graham Cooks; Daniel Raftery
Journal:  Anal Bioanal Chem       Date:  2006-07-05       Impact factor: 4.142

5.  Early detection of recurrent breast cancer using metabolite profiling.

Authors:  Vincent M Asiago; Leiddy Z Alvarado; Narasimhamurthy Shanaiah; G A Nagana Gowda; Kwadwo Owusu-Sarfo; Robert A Ballas; Daniel Raftery
Journal:  Cancer Res       Date:  2010-10-19       Impact factor: 12.701

6.  Urinary metabonomic study on colorectal cancer.

Authors:  Yunping Qiu; Guoxiang Cai; Mingming Su; Tianlu Chen; Yumin Liu; Ye Xu; Yan Ni; Aihua Zhao; Sanjun Cai; Lisa X Xu; Wei Jia
Journal:  J Proteome Res       Date:  2010-03-05       Impact factor: 4.466

7.  1H NMR, GC-EI-TOFMS, and data set correlation for fruit metabolomics: application to spatial metabolite analysis in melon.

Authors:  Benoit Biais; J William Allwood; Catherine Deborde; Yun Xu; Mickael Maucourt; Bertrand Beauvoit; Warwick B Dunn; Daniel Jacob; Royston Goodacre; Dominique Rolin; Annick Moing
Journal:  Anal Chem       Date:  2009-04-15       Impact factor: 6.986

8.  Biomarker Discovery and Translation in Metabolomics.

Authors:  G A Nagana Gowda; D Raftery
Journal:  Curr Metabolomics       Date:  2013

9.  Metabonomics identifies serum metabolite markers of colorectal cancer.

Authors:  Binbin Tan; Yunping Qiu; Xia Zou; Tianlu Chen; Guoxiang Xie; Yu Cheng; Taotao Dong; Linjing Zhao; Bo Feng; Xiaofang Hu; Lisa X Xu; Aihua Zhao; Menghui Zhang; Guoxiang Cai; Sanjun Cai; Zhanxiang Zhou; Minhua Zheng; Yan Zhang; Wei Jia
Journal:  J Proteome Res       Date:  2013-05-29       Impact factor: 4.466

10.  Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods.

Authors:  Jian Zhang; Jeremiah Bowers; Lingyan Liu; Siwei Wei; G A Nagana Gowda; Zane Hammoud; Daniel Raftery
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

View more
  12 in total

Review 1.  Recent Advances in NMR-Based Metabolomics.

Authors:  G A Nagana Gowda; Daniel Raftery
Journal:  Anal Chem       Date:  2016-12-02       Impact factor: 6.986

2.  Polybrominated Diphenyl Ethers and Gut Microbiome Modulate Metabolic Syndrome-Related Aqueous Metabolites in Mice.

Authors:  David K Scoville; Cindy Yanfei Li; Dongfang Wang; Joseph L Dempsey; Daniel Raftery; Sridhar Mani; Haiwei Gu; Julia Yue Cui
Journal:  Drug Metab Dispos       Date:  2019-05-23       Impact factor: 3.922

3.  Metabolomics with multi-block modelling of mass spectrometry and nuclear magnetic resonance in order to discriminate Haplosclerida marine sponges.

Authors:  Mehdi A Beniddir; Laurence Le Moyec; Mohamed N Triba; Arlette Longeon; Alexandre Deville; Alain Blond; Van Cuong Pham; Nicole J de Voogd; Marie-Lise Bourguet-Kondracki
Journal:  Anal Bioanal Chem       Date:  2022-06-20       Impact factor: 4.478

4.  Plasma metabolomic profiles for colorectal cancer precursors in women.

Authors:  Dong Hang; Oana A Zeleznik; Jiayi Lu; Amit D Joshi; Kana Wu; Zhibin Hu; Hongbing Shen; Clary B Clish; Liming Liang; A Heather Eliassen; Shuji Ogino; Jeffrey A Meyerhardt; Andrew T Chan; Mingyang Song
Journal:  Eur J Epidemiol       Date:  2022-01-15       Impact factor: 12.434

5.  Stratification of cancer and diabetes based on circulating levels of formate and glucose.

Authors:  Matthias Pietzke; Salvador Fernandez Arroyo; David Sumpton; Gillian M Mackay; Begoña Martin-Castillo; Jordi Camps; Jorge Joven; Javier A Menendez; Alexei Vazquez
Journal:  Cancer Metab       Date:  2019-04-24

6.  Identifying Significant Metabolic Pathways Using Multi-Block Partial Least-Squares Analysis.

Authors:  Lingli Deng; Fanjing Guo; Kian-Kai Cheng; Jiangjiang Zhu; Haiwei Gu; Daniel Raftery; Jiyang Dong
Journal:  J Proteome Res       Date:  2020-03-27       Impact factor: 4.466

7.  Comparative metabolomics revealing Staphylococcus aureus metabolic response to different antibiotics.

Authors:  Katie Schelli; Fanyi Zhong; Jiangjiang Zhu
Journal:  Microb Biotechnol       Date:  2017-08-16       Impact factor: 5.813

8.  Disturbance in Plasma Metabolic Profile in Different Types of Human Cytomegalovirus-Induced Liver Injury in Infants.

Authors:  Wei-Wei Li; Jin-Jun Shan; Li-Li Lin; Tong Xie; Li-Li He; Yan Yang; Shou-Chuan Wang
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

9.  Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.

Authors:  Pawadee Lohavanichbutr; Yuzheng Zhang; Pei Wang; Haiwei Gu; G A Nagana Gowda; Danijel Djukovic; Matthew F Buas; Daniel Raftery; Chu Chen
Journal:  PLoS One       Date:  2018-09-20       Impact factor: 3.240

10.  Integrated Serum and Fecal Metabolomics Study of Collagen-Induced Arthritis Rats and the Therapeutic Effects of the Zushima Tablet.

Authors:  Jinjun Shan; Linxiu Peng; Wenjuan Qian; Tong Xie; An Kang; Bei Gao; Liuqing Di
Journal:  Front Pharmacol       Date:  2018-08-14       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.